Target intelligence / Profile preview

GPN-loop GTPase 3 (GPN3)

Target
GPN3
Molecular classification
GTPase, Assembly chaperone (pol II assembly factor), Other (unique GPN-loop GTPase family)
01

Overview

GPN-loop GTPase 3 (GPN3) is a eukaryotic member of the GPN-loop GTPase family, defined by a conserved Gly-Pro-Asn (GPN) motif in the GTPase domain[1][2]. In eukaryotes, three paralogs exist (GPN1, GPN2, GPN3), each playing an essential role in the biogenesis of RNA polymerase II by functioning as assembly chaperones—specifically, they facilitate the assembly and nuclear import of the 12-subunit RNA polymerase II complex[1][2][3]. Depletion or mutation of GPN3 leads to cytoplasmic accumulation of RNA polymerase II subunits and is lethal in yeast and other eukaryotes[1]. GPN-loop GTPases undergo large conformational changes upon GTP hydrolysis, enabling them to bind hydrophobic regions of protein subunits and coordinate their assembly and release[1][2][3]. No therapeutic drugs specifically targeting GPN3 are documented; rather, its critical role in basic cellular processes makes it unlikely to be a selective drug target[1][2][3]. There is no current evidence linking GPN3 directly to specific diseases, but its essential function makes it a fundamental factor in cell biology.

Other names
ATPBD1CAD-009UNQ1876/PRO4319MGC14560ATP-binding domain 1 family member Cprotein x 0004
02

Biological functions

RNA polymerase II biogenesisProtein complex assembly chaperone activity
03

Disease associations

Other (no direct disease association established; essential for viability)
04

Safety considerations

Essential for cell viability (loss of function is lethal)

Beyond the preview

Go deeper on GPN-loop GTPase 3 (GPN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPN-loop GTPase 3 (GPN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call